LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$18.65
$37,300
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$19.08
$95,385
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
8,000
$19.03
$152,200
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$18.99
$37,980
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$18.4
$91,985
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$18.48
$36,960
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$17.42
$34,830
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$18.56
$92,815
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$18.77
$37,540
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$18.68
$37,352
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$17.75
$88,730
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$17.34
$34,670
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$17.87
$35,740
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$17.9
$89,495
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$17.68
$35,362
Option
MAYNOR KATHLEEN Aofficer: VP of Regulary Affairs & QAofficer: VP of Regulary Affairs..
Common Stock
20,000
$4.5
$90,000
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$16.07
$32,142
Sale
MAYNOR KATHLEEN Aofficer: VP of Regulary Affairs & QAofficer: VP of Regulary Affairs..
Common Stock
20,000
$4.5
$90,000
Option
MAYNOR KATHLEEN Aofficer: VP of Regulary Affairs & QAofficer: VP of Regulary Affairs..
Employee Stock Option (Right to Buy)
20,000
$4.5
$90,000
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$16.69
$83,465
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$17.24
$34,470
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$17.09
$34,180
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$17.67
$88,345
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$17.84
$35,680
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$17.7
$35,400
Option
MAYNOR KATHLEEN Aofficer: VP of Regulary Affairs & QAofficer: VP of Regulary Affairs..
Common Stock
20,000
$4.5
$90,000
Option
MAYNOR KATHLEEN Aofficer: VP of Regulary Affairs & QAofficer: VP of Regulary Affairs..
Employee Stock Option (Right to Buy)
20,000
$4.5
$90,000
Sale
MAYNOR KATHLEEN Aofficer: VP of Regulary Affairs & QAofficer: VP of Regulary Affairs..
Common Stock
20,000
$4.5
$90,000
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$17.63
$88,140
Sale
APFELBERG DAVID Bdirectordirector
Common Stock
5,000
$17.8
$89,000
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$17.95
$35,902
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$13.8
$27,600
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$13.99
$69,940
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$14.02
$28,040
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$13.62
$27,238
Option
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Common Stock
5,000
$4.25
$21,250
Option
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Employee Stock Option (Right to Buy)
5,000
$4.25
$21,250
Sale
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Common Stock
5,000
$4.25
$21,250
Sale
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Common Stock
11,000
$4.25
$46,750
Option
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Employee Stock Option (Right to Buy)
23,500
$9.13
$214,438
Option
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Common Stock
23,500
$9.13
$214,438
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$13.73
$68,625
Option
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Common Stock
1,500
$4.25
$6,375
Sale
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Common Stock
1,500
$4.25
$6,375
Option
SANTILLI RONALD Jofficer: Outgoing EVP and CFOofficer: Outgoing EVP and CFO
Employee Stock Option (Right to Buy)
1,500
$4.25
$6,375
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$13.05
$26,096
Sale
LEVERNIER MICHAEL Jofficer: VP of Clinical Developmentofficer: VP of Clinical Develop..
Common Stock
2,000
$12.27
$24,536
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
2,000
$12.22
$24,436
Sale
CONNORS KEVIN Pdirector, officer: President & CEOdirector, officer: President & ..
Common Stock
5,000
$12.46
$62,300
Sale
GOLLNICK DAVID Adirectordirector
Common Stock
20,000
$12.57
$251,380
Showing 550 to 600 of 642 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.